HIV/AIDS Testing

OraQuick ADVANCE to be centerpiece of expanded HIV testing in Philadelphia

Published in Vaccine Weekly, January 3rd, 2007

OraSure Technologies, Inc. (OSUR) announced that its OraQuick ADVANCE Rapid HIV 1/2 Antibody Test will be the centerpiece of a planned initiative in the city of Philadelphia to provide oral fluid rapid HIV 1/2 testing to populations that are traditionally underserved and in many instances unable to access routine medical care.

The initiative is being made possible through an initial $1.5 million in increased funding to expand local HIV/AIDS testing and treatment programs, the largest increase of its kind in the history of Pennsylvania.

The announcement was made by State Sen. Vincent Hughes (D-Phila.) and Dr. Calvin B. Johnson, Secretary of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2007-01-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry